BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3831898)

  • 1. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
    Cwik J
    Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production of KU-ABO preparations in hospitals for the treatment of hemolytic disease of the newborn].
    Cwik J; Dimmich H; Przudzik J
    Pediatr Pol; 1985 Sep; 60(9):658-61. PubMed ID: 3831899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
    Cwik J
    Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
    Avdeeva RA; Kopp VD; Vasil'eva AF
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
    [No Abstract]   [Full Text] [Related]  

  • 8. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
    Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
    [No Abstract]   [Full Text] [Related]  

  • 9. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V; Sauer J
    Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
    Lange MM
    Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 15. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic and therapeutic problems in ABO hemolytic disease of the newborn].
    Sławek Z; Banaszkiewicz A; Pszeniczna E; Stolarz E; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):104-10. PubMed ID: 3239364
    [No Abstract]   [Full Text] [Related]  

  • 17. ABO haemolytic disease: an important cause of neonatal morbidity.
    Jadhav M; Devarajan LV
    Indian Pediatr; 1972 May; 9(5):246-51. PubMed ID: 4675282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic disease of newborn].
    Speilmann W
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease of the newborn with rarely occurring blood group antibodies].
    Dzierzkowa-Borodej W; Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):366-8. PubMed ID: 4193016
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.